(1)
Nidal Karim Al-Rahal, Oula Abdullah Najim, Ahmed Shemran Alwataify, Israa Mustafa Almusawi, Ahmed Ibrahim Shukr, Yaser Shanyor Alsalman. Emicizumab Prophylaxis Every Four Weeks Among Hemophilia a With Inhibitors in Iraq, Multicenter Study. JRTDD 2022, 5, 477-482.